1B)  Species-specific research is critical for selecting and developing active ingredients for pets. It ensures that all nutritional components are both effective and safe for the targeted species. Different companion animals possess distinct nutritional requirements, unique microbiotas, specific anatomical diferences and physiological responses. Therefore, relying on human data alone is not recommended for product development. Data from non-target species, including human, may provide initial reference points, but it does not guarantee efficacy, safety, or regulatory compliance in pet nutrition. Only species committed research can achieve these standards as assuming that human data is extensible companion animals is erroneous. Precise testing within a targeted species is the appropriate benchmark for active ingredients for animal nutrition. Beyond species specificity, considerations for age and stage of life are also key factors. 

 1C)  The humanization of pets impacts consumer behavior in several ways, both positively and negatively. Consumers often confer health benefits that they desire for themselves to their pets. This often results in pet owners taking steps to self educate and apply learnings from humans to their pets. However, this can generate distorted expectations on product performance as well as safety.  

Consumer awareness and interest on the impacts of so called industrialized diets on human health is resulting in more focused attention on similarly categorized diets for pets. Consumer interest in supplements for pets (vitamins, minerals, probiotics, etc.) continues in parallel with the same motivation that drives human interest in dietary supplementation; how can I, and my pet, attain better lifespan and healthspan”? Increasingly this interest draws attention to the importance of the intestinal microbiome and the interconnected role the microbiome plays on all aspects of human and animal health.

Many want their companions to have a diet aligned with their values. As awareness of animal welfare grows, so does interest in products that reflect functional, ethical, sustainable, and scientifically supported outcomes. This drives the search for more bespoke health and nutrition solutions, which can create misguided expectations. This can manifest in the marketing of “luxury” products and formulas that make exaggerated claims, such as immediate results or effects beyond the animal’s biological limits. There can also be confusion between real well-being and practices inspired by human care that are not always suitable for other species. What the market really wants is products proven effective for the target species, communicated transparently, and with continuous education of consumers.

1F) Scientific evidence is essential for credibility, trust, and transparency for all products, especially products with health claims like food and supplements. Prioritizing clinical studies that use rigorous designs and are practically feasible helps build consumer confidence. This ensures reliable, relevant, and commercially applicable results.

Experimental design should be structured to directly substantiate product claims, avoiding unnecessary complexity or high costs, and preventing scattered data. Clear, objective methodologies suited to the intended effect, using quantifiable metrics, clinical assessments, and veterinary-accepted parameters.

In this way, scientifically sound yet realistic evidence that can safely support the proposed benefits while balancing technical rigor, operational efficiency, and relevance to pet owners, veterinarians, and other stakeholders in the sector.

1L)  Yes, a clear and growing trend is the inclusion of targeted ingredients, specifically those supporting immune and joint health, in pet supplements designed for healthy aging.  Healthy aging is often referred to as the combination of lifespan and healthspan.  Like people, pet owners want not just a long life but a healthy life.  Immune and joint support are becoming the foundational focus for maintaining vitality in adult and senior pets. The expectation of functionality is reasonable.  

An example is beta-1,3/1,6-glucans that are extracted from yeast through a process that preserves its molecular structure. This confers high bioactivity. The ingredient offers benefits directly related to healthy aging. These include strengthening the immune system, improving vaccine response, and supporting joint health. It also contributes to glucose control in obese animals. This is important for longevity and for preventing chronic disease. These effects make beta-glucans an increasingly sought-after ingredient in functional formulations that support companion animals across various life stages.

In the joint care segment, new-generation ingredients, such as chondroitin sulfate produced by precision fermentation, are advancing. This chondroitin is free of animal origin. The technology meets market demand for greater safety by eliminating risks associated with animal-derived raw materials. It also minimizes allergic reactions and advances sustainability, meeting current expectations from pet owners and manufacturers. Additionally, it offers greater purity and bioavailability. These are essential for effective long-term joint support.

In short, ingredients like highly bioactive beta-glucans and chondroitin from clean biotechnology are gaining prominence in supplement formulations for healthy aging. They combine enhanced immunity, preserved mobility, and superior safety. This aligns with what modern pet owners expect when investing in their pet’s long-term health.

4A)  In the next 5 to 10 years, the pet supplement industry’s credibility and long-term success will depend on mutliple pillars: science, standardization, quality and regulatory harmonization.

The market will increasingly demand scientific evidence that transparently and reliably supports product claims. Supplements that include studies using consistent methods, clear parameters, and sound research practices will tend to stand out and aid in establishing a positive reputation with veterinarians, pet owners, and regulatory bodies.

Furthermore, standardizing ingredients, processes, and analytical parameters will be crucial to ensure batch consistency, predictable product outcomes, and confidence in formulations. Uniform evaluation methods and quality criteria will increase technical rigor, streamline regulatory approvals, and enable more consise product comparisons, directly benefitting both manufacturers and consumers.

The quality of the entire production chain, from selecting raw materials to final product control, will remain a key differentiator by ensuring consistent product safety, regulatory compliance, and consumer trust. Companies that adopt rigorous quality control, traceability, and regulatory compliance will be seen as benchmarks in safety and excellence, helping them secure customer loyalty and competitive advantage.

Together, these pillars will establish new industry standards. This will ensure pet supplements are appropriately regulated, safe, effective, and clearly labeled; to better foster trust and informed choices. By leading with these principles, industry can drive relevance, support sustainable growth, and shape the industry’s future over the coming decade.

4B) Consumer trust can not be limited to a focus on one particular área. Science, regulation and education are all incredibly importante. Stakeholders with interest in education will see the world through this lens. 

One paradigm is the potential to significantly increase consumer confidence in pet supplements via the adoption of a unified scientific standard to substantiate product efficacy and quality.  Such a unified scientific standard must also be recognized, appreciated and adopted by regulators.  Leading edge science, many times modeled by research in the human field, should be embraced and not unnessarily be impaired by inconsistency in regulatory strandards across markets.

The adoption of standardized scientific criteria, including minimum study methodologies, consistent analytical parameters, and clear requirements for supporting claims, would bring greater transparency, predictability, and comparability across brands and formulations. This transformation would create an environment where consumers could trust every claim presented on the label, as the evidence would be robust and consistent across the industry.

A standardized framework would also encourage rigorous quality control by ensuring consistency between batches and the use of high-quality raw materials. This enhanced technical compliance would give pet owners and veterinarians clear confidence in choosing and recommending supplements, knowing the products meet consistent standards for safety and effectiveness.

Effective education can then be built and delivered upon on a solid foundation of scientific rigor, regulatory recognition and harmonization.  A robust 3 pronged approach that prioritizes benefits to consumers and animals.